No Data
No Data
Painful Week for Retail Investors Invested in Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) After 7.0% Drop, Institutions Also Suffered Losses
Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Held Back By Insufficient Growth Even After Shares Climb 26%
Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
Investors in Guizhou Bailing Group Pharmaceutical (SZSE:002424) From Five Years Ago Are Still Down 64%, Even After 9.8% Gain This Past Week
Both Individual Investors Who Control a Good Portion of Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Along With Institutions Must Be Dismayed After Last Week's 7.7% Decrease
Is Guizhou Bailing Group Pharmaceutical (SZSE:002424) A Risky Investment?
No Data